Commitments and Contingencies (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Commitments and Contingencies |
|
| Schedule of future minimum lease payments under financing leases |
For the Six Months Ending June 30, 2026 | | Amount | | | | $ | | 2026 - Remaining | | | 30,702 | | 2027 | | | 61,406 | | 2028 | | | 61,405 | | 2029 | | | 61,404 | | 2030 | | | 61,406 | | Greater than 5 years | | | 84,417 | | Total | | | 360,740 | | Less: Amount representing interest | | | (24,869 | ) | Present value of minimum lease payments | | | 335,871 | | |
|
| Schedule of operating lease right-of-use assets |
| | June 30, 2026 | | | December 31, 2025 | | | | $ | | | $ | | Operating right-of-use assets | | | 338,795 | | | | 495,749 | | | | | | | | | | | Operating lease liabilities, current portion | | | 204,724 | | | | 250,336 | | Operating lease liabilities, long term | | | 157,478 | | | | 276,558 | | Total operating lease liabilities | | | 362,202 | | | | 632,441 | | | | | | | | | | | Weighted average remaining lease (months) | | | 28 | | | | 39 | | Weighted average discount rate | | | 4.26 | % | | | 4.28 | % | |
|
| Schedule of future minimum lease payments under operating leases |
For the Six Months Ending June 30, 2026 | | Amount | | | | $ | | 2026 - Remaining | | | 120,405 | | 2027 | | | 159,737 | | 2028 | | | 82,945 | | 2029 | | | 13,666 | | Total | | | 376,753 | | Less: imputed interest | | | (14,551 | ) | Total Operating Lease Liabilities | | | 362,202 | |
|
| Schedule of short-term lease costs due |
For the Six Months Ending June 30, 2026 | | Amount | | | | | | 2026 - Remaining | | | 23,793 | | 2027 | | | - | | Total Operating Lease Liabilities | | | 23,793 | |
|
| Schedule of grants repayable |
For the Six Months Ending June 30, 2026 | | Amount | | | | | | 2026 - Remaining | | | 101,951 | | 2027 | | | 103,688 | | 2028 | | | 112,557 | | 2029 | | | 56,949 | | 2030 | | | 57,017 | | Greater than 5 years | | | 130,700 | | Total Grants Repayable | | | 562,862 | |
|
| Schedule of long-term debt payable |
For the Six Months Ending June 30, 2026 | | Amount | | | | $ | | 2026 - Remaining | | | 1,139,483 | | 2027 | | | 2,638,076 | | 2028 | | | 3,547,122 | | 2029 | | | 289,487 | | 2030 | | | 262,206 | | Greater than 5 years | | | 674,834 | | Total | | | 8,551,208 | | Less: amount representing interest | | | (1,499,373 | ) | Total Long-Term Debt | | | 7,051,835 | |
|
| Schedule of annual payments of collaborative agreement obligations |
| | Total Amount Remaining | | | 2026 | | | | $ | | | $ | | National University of Taiwan | | | 510,000 | | | | 510,000 | | MD Anderson Cancer Center | | | 163,546 | | | | 163,546 | | Guys and St Thomas | | | 129,127 | | | | 129,127 | | Xenetic Biosciences | | | 55,305 | | | | 55,305 | | National University of Taiwan | | | 160,900 | | | | 160,900 | | Gustave Roussy | | | 84,942 | | | | 84,942 | | Total Collaborative Obligations | | | 1,103,820 | | | | 1,103,820 | |
|
| Schedule of future principal payments of convertible notes payable |
For the Six Months Ending June 30, 2026 | | Amount | | | | $ | | 2026 - Remaining | | | 2,500,000 | | 2027 | | | 883,333 | | Total Payments | | | 3,383,333 | | | | | | | Debt Carrying Value | | | 3,383,333 | | Debt discount | | | (840,080 | ) | Current portion of convertible note payable, net | | | 2,543,253 | | | | | | | Debt Carrying Value | | | - | | Debt discount | | | - | | Convertible note payable, net of current portion | | | - | |
For the Six Months Ending June 30, 2026 | | Amount | | | | $ | | 2026 - Remaining | | | 800,000 | | 2027 | | | 1,590,000 | | Total Payments | | | 2,390,000 | | | | | | | Debt Carrying Value | | | 1,600,000 | | Debt discount | | | (722,668 | ) | Current portion of convertible note payable, net | | | 877,332 | | | | | | | Debt Carrying Value | | | 790,000 | | Debt discount | | | (550,193 | ) | Convertible note payable, net of current portion | | | 239,807 | |
For the Six Months Ending June 30, 2026 | | Amount | | | | $ | | 2026 - Remaining | | | 3,300,000 | | 2027 | | | 2,473,333 | | Total Payments | | | 5,773,333 | | | | | | | Debt Carrying Value | | | 4,983,333 | | Debt discount | | | (1,562,748 | ) | Current portion of convertible note payable, net | | | 3,420,585 | | | | | | | Debt Carrying Value | | | 790,000 | | Debt discount | | | (550,193 | ) | Convertible note payable, net of current portion | | | 239,807 | |
|
| Schedule of commitments in respect of corporate goals and performance based awards |
Total | | | | | Amortized | | | Amortized | | | Amortized | | | Amortized | | | Un-Amortized | | Award | | | Vesting | | 2026 | | | 2025 | | | 2024 | | | 2023 | | | 2026 | | $ | | | Year | | $ | | | $ | | | $ | | | $ | | | $ | | | 242,902 | | | 2024 | | | - | | | | - | | | | 148,132 | | | | 94,770 | | | | - | | | 218,081 | | | 2025 | | | 0 | | | | 66,990 | | | | 103,578 | | | | 47,513 | | | | - | | | 207,580 | | | 2026 | | | 32,495 | | | | 58,062 | | | | 69,116 | | | | 31,703 | | | | 16,204 | | | 668,563 | | | | | | 32,495 | | | | 125,052 | | | | 320,826 | | | | 173,986 | | | | 16,204 | |
|
| Schedule of outcomes related to the prescribed performance targets on the outstanding awards |
Total | | | | | Amortized | | | Amortized | | | Un-Amortized | | | Cancelled | | Award | | | Vesting | | 2026 | | | 2025 | | | 2026 | | | 2025 | | $ | | | Year | | $ | | | $ | | | $ | | | $ | | | 545,026 | | | 2026 | | | 33,786 | | | | 128,920 | | | | - | | | | 382,320 | | | 545,015 | | | 2027 | | | 40,510 | | | | 64,548 | | | | 56,026 | | | | 383,931 | | | 545,006 | | | 2028 | | | 27,565 | | | | 43,013 | | | | 89,888 | | | | 384,540 | | | 1,635,047 | | | | | | 101,861 | | | | 236,481 | | | | 145,914 | | | | 1,150,791 | |
|